By:Ashley Krull, Ph.D.
Telegraft Contributing Editor
Mayo Clinic Rochester
Rochester, United States
Bernd Giebel, Ph.D.
Institute for Transfusion Medicine
University Hospital Essen
University of Duisburg-EssenEssen, Germany
Dr. Bernd Giebel directs a research lab within the Institute of Transfusion Medicine at the University Hospital Essen and the University of Duisburg-Essen in Essen, Germany. Dr. Giebel’s career has spanned work in hematopoietic stem and progenitor cells to extracellular vesicles (EVs). Currently, Dr. Giebel’s lab is focused on optimizing the utilization of EVs and exosomes for therapeutic applications. Dr. Giebel also serves as the co-chair of the ISCT Exosomes Committee. Telegraft Editorial Board member Ashley Krull enjoyed a New Year’s chat with Bernd during which he shared insights into what makes exosomes and EVs such interesting subjects for research and therapeutic development as well as tips for taking advantage of the next ISCT Annual Meeting in Paris. This conversation also provides a nice framework for anyone thinking about how to develop these novel therapeutics to suit particular patient populations.